What is the latest nomenclature for eosinophilic disorders of the Gastrointestinal (GI) tract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Latest Nomenclature of Eosinophilic Disorders of the GI Tract

The current standard nomenclature for eosinophilic disorders of the gastrointestinal tract follows a two-tier framework that first identifies the specific location of involvement, followed by more granular characterization of disease involvement. 1

Primary Nomenclature Evolution

The nomenclature for eosinophilic disorders of the GI tract has evolved significantly over the past two decades:

Eosinophilic Esophagitis (EoE)

  • Initially abbreviated as "EE" in 2007 2
  • Changed to "EoE" in 2011 to avoid confusion with "erosive esophagitis" 2
  • Current definition: a chronic, immune/antigen-mediated disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation 2

Non-Esophageal Eosinophilic Disorders

The current standardized nomenclature for non-esophageal involvement includes:

  • Eosinophilic Gastritis (EoG): Stomach involvement only 3
  • Eosinophilic Enteritis (EoN): Small bowel involvement only 3
  • Eosinophilic Duodenitis (EoD): Specific duodenal involvement 3
  • Eosinophilic Colitis (EoC): Colon involvement only 3
  • Eosinophilic Gastroenteritis (EGE): Involvement of multiple GI segments 3, 4

Current Diagnostic Framework

The diagnostic criteria for eosinophilic disorders have also evolved:

  • For EoE: ≥15 eosinophils per high-power field (or ~60 eosinophils per mm²) on esophageal biopsy, with symptoms of esophageal dysfunction, after comprehensive assessment of non-EoE disorders 2
  • Important change: The 2018 guidelines removed the PPI trial requirement that was previously part of the diagnostic algorithm 2

Multi-Segment Involvement Terminology

For patients with involvement of multiple GI segments, there are two competing terminologies:

  1. "Non-EoE EGID and EoE"
  2. "Non-EoE EGID with esophageal involvement (EI)" 5

A survey of 91 experts showed that 61% preferred the term "non-EoE EGID with EI" since EoE is defined as isolated to the esophagus by current diagnostic criteria 5.

Differential Diagnosis Considerations

When diagnosing eosinophilic disorders, it's essential to rule out other causes of GI eosinophilia, including:

  • Gastroesophageal reflux disease (GERD)
  • Crohn's disease
  • Connective tissue diseases
  • Hypereosinophilic syndrome
  • Infections
  • Drug hypersensitivity reactions
  • Achalasia
  • Graft-versus-host disease
  • Vasculitis
  • Pemphigoid/pemphigus 2, 6

Clinical Implications

Understanding the correct nomenclature is crucial because:

  • Disease burden and symptoms are generally higher in non-EoE EGIDs than in isolated EoE 5
  • Treatment approaches may differ based on the specific segments involved
  • Patients with EoE should be monitored for potential development of other EGIDs 7

The non-EoE EGIDs remain understudied and likely underdiagnosed, partly due to previous lack of clarity in terminology 1. The recent standardization of nomenclature represents an important step toward improved diagnosis, research, and treatment of these conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis.

The American journal of gastroenterology, 2022

Research

Eosinophilic Esophagitis and Gastroenteritis.

Current allergy and asthma reports, 2015

Research

Eosinophil Involvement Outside the Esophagus in Eosinophilic Esophagitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2024

Guideline

Esophagitis Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.